Klotho Neurosciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Klotho Neurosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q3 2024.
  • Klotho Neurosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.87M, a 2220% decline year-over-year.
  • Klotho Neurosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$4.22M, a 352% decline year-over-year.
  • Klotho Neurosciences, Inc. annual Operating Income (Loss) for 2023 was -$1.3M, a 98% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.22M -$2.87M -$2.75M -2220% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$1.47M -$396K -$151K -62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$1.32M -$343K -$17K -5.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-23
Q4 2023 -$1.3M -$607K -$368K -153% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-17
Q3 2023 -$933K -$124K +$56K +31.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$989K -$244K -$11.5K -4.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$978K -$326K -$321K -6402% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-23
Q4 2022 -$657K -$240K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-17
Q3 2022 -$180K -$180K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$233K -$229K -6529% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$5.01K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-24
Q3 2021 -$16* Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.51K Mar 16, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.